SSX-4 peptides presented by HLA class II molecules
AssigneeLudwig Institute for Cancer Research
InventorsDanila Valmori, Maha Ayyoub
Life of this patent
Estimating the term…
Abstract
The invention describes HLA class II binding peptides encoded by the SSX-4 tumor associated gene, as well as nucleic acids encoding such peptides and antibodies relating thereto. The peptides stimulate the activity and proliferation of CD4+ T lymphocytes. Methods and products also are provided for diagnosing and treating conditions characterized by expression of the SSX-4 gene.
Claims17
An isolated SSX-4 HLA class II-binding peptide comprising an amino acid sequence selected from the group set forth as SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10, or a functional variant thereof comprising 1-5 amino acid substitutions, wherein the HLA class II-binding peptide does not include a full length SSX-4 protein.
A composition comprising an isolated HLA class I-binding peptide and an isolated SSX-4 HLA class II-binding peptide, wherein the isolated SSX-4 HLA class II-binding peptide comprises an amino acid sequence selected from the group set forth as SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10, or a functional variant thereof comprising 1-5 amino acid substitutions, and wherein the HLA class II binding peptide does not include the full length SSX-4 protein.
-74. (canceled)
Dependencies are inferred from the claim text.